Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA and Azacitidine in Older AML
NCT01067274Phase 3Withdrawn
- Sponsor
- Acute Leukemia French Association
- Start
- Apr 2010
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tretinoin, azacitidine in acute myeloid leukemia (AML), sponsored by Acute Leukemia French Association. Planned start Apr 2010; status: withdrawn.
02
Drugs
tretinoinazacitidine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01067274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01067274.